{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1029.125","meta":{"versionId":"21","lastUpdated":"2021-06-11T01:01:24.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125","version":"20210611","name":"Maternal Drug Use","status":"active","date":"2021-06-11T01:01:24-04:00","publisher":"Joint Commission","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","concept":[{"code":"P04.11","display":"Newborn affected by maternal antineoplastic chemotherapy"},{"code":"P04.12","display":"Newborn affected by maternal cytotoxic drugs"},{"code":"P04.13","display":"Newborn affected by maternal use of anticonvulsants"},{"code":"P04.14","display":"Newborn affected by maternal use of opiates"},{"code":"P04.15","display":"Newborn affected by maternal use of antidepressants"},{"code":"P04.16","display":"Newborn affected by maternal use of amphetamines"},{"code":"P04.17","display":"Newborn affected by maternal use of sedative-hypnotics"},{"code":"P04.18","display":"Newborn affected by other maternal medication"},{"code":"P04.19","display":"Newborn affected by maternal use of unspecified medication"},{"code":"P04.1A","display":"Newborn affected by maternal use of anxiolytics"},{"code":"P04.3","display":"Newborn affected by maternal use of alcohol"},{"code":"P04.40","display":"Newborn affected by maternal use of unspecified drugs of addiction"},{"code":"P04.41","display":"Newborn affected by maternal use of cocaine"},{"code":"P04.42","display":"Newborn affected by maternal use of hallucinogens"},{"code":"P04.49","display":"Newborn affected by maternal use of other drugs of addiction"},{"code":"P04.81","display":"Newborn affected by maternal use of cannabis"},{"code":"P04.89","display":"Newborn affected by other maternal noxious substances"},{"code":"P96.1","display":"Neonatal withdrawal symptoms from maternal use of drugs of addiction"},{"code":"P96.2","display":"Withdrawal symptoms from therapeutic use of drugs in newborn"}]}]},"expansion":{"identifier":"urn:uuid:2f18457e-ac67-4e37-b6ae-6ef877fbe422","timestamp":"2022-06-10T09:33:52-04:00","total":19,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.11","display":"Newborn affected by maternal antineoplastic chemotherapy"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.12","display":"Newborn affected by maternal cytotoxic drugs"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.13","display":"Newborn affected by maternal use of anticonvulsants"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.14","display":"Newborn affected by maternal use of opiates"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.15","display":"Newborn affected by maternal use of antidepressants"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.16","display":"Newborn affected by maternal use of amphetamines"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.17","display":"Newborn affected by maternal use of sedative-hypnotics"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.18","display":"Newborn affected by other maternal medication"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.19","display":"Newborn affected by maternal use of unspecified medication"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.1A","display":"Newborn affected by maternal use of anxiolytics"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.3","display":"Newborn affected by maternal use of alcohol"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.40","display":"Newborn affected by maternal use of unspecified drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.41","display":"Newborn affected by maternal use of cocaine"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.42","display":"Newborn affected by maternal use of hallucinogens"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.49","display":"Newborn affected by maternal use of other drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.81","display":"Newborn affected by maternal use of cannabis"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P04.89","display":"Newborn affected by other maternal noxious substances"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P96.1","display":"Neonatal withdrawal symptoms from maternal use of drugs of addiction"},{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"P96.2","display":"Withdrawal symptoms from therapeutic use of drugs in newborn"}]}}